Your browser doesn't support javascript.
loading
Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer.
Flores-Morales, Amilcar; Bergmann, Tobias B; Lavallee, Charlotte; Batth, Tanveer S; Lin, Dong; Lerdrup, Mads; Friis, Stine; Bartels, Anette; Kristensen, Gitte; Krzyzanowska, Agnieszka; Xue, Hui; Fazli, Ladan; Hansen, Klaus H; Røder, Martin A; Brasso, Klaus; Moreira, José M; Bjartell, Anders; Wang, Yuzhuo; Olsen, Jesper V; Collins, Colin C; Iglesias-Gato, Diego.
Afiliação
  • Flores-Morales A; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Bergmann TB; The Danish Cancer Society, Copenhagen, Denmark.
  • Lavallee C; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Batth TS; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Lin D; The Danish Cancer Society, Copenhagen, Denmark.
  • Lerdrup M; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Friis S; The Danish Cancer Society, Copenhagen, Denmark.
  • Bartels A; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Kristensen G; Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
  • Krzyzanowska A; Biotech Research and Innovation Center, University of Copenhagen, Copenhagen, Denmark.
  • Xue H; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Fazli L; The Danish Cancer Society, Copenhagen, Denmark.
  • Hansen KH; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Røder MA; The Danish Cancer Society, Copenhagen, Denmark.
  • Brasso K; Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Moreira JM; Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund, Sweden.
  • Bjartell A; Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
  • Wang Y; Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
  • Olsen JV; Biotech Research and Innovation Center, University of Copenhagen, Copenhagen, Denmark.
  • Collins CC; Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Iglesias-Gato D; Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Clin Cancer Res ; 25(2): 595-608, 2019 01 15.
Article em En | MEDLINE | ID: mdl-30274982

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Carcinoma Neuroendócrino / Neoplasias de Próstata Resistentes à Castração / Proteogenômica Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Carcinoma Neuroendócrino / Neoplasias de Próstata Resistentes à Castração / Proteogenômica Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Estados Unidos